JYHB2300164 | 格隆溴铵吸入粉雾剂 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs | Supplementary Application | 2023-03-07 | | | | | view |
JYHB2400278 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-06-13 | | | | | view |
JYHB2400605 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-11-19 | | | | | view |
CYHL2300081 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(4) | Generic Drug | 2023-06-27 | | Respirent Pharmaceuticals Co Ltd | | | view |
JYHB2300163 | 格隆溴铵吸入粉雾剂 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs | Supplementary Application | 2023-03-07 | | | | | view |
JYHB2300340 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-06-19 | | | | | view |
CYHL2300031 | 格隆溴铵吸入粉雾剂 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs(4) | Generic Drug | 2023-03-02 | | CF PharmTech Inc | | | view |
JYHB2400606 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-11-19 | | | | | view |
JYHB2300339 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-06-19 | | | | | view |
CXHB2101021 | 格隆溴铵吸入粉雾剂 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs(原3.1) | Supplementary Application | 2021-05-14 | | Sichuan Haisco Pharmaceutical Co Ltd | | | view |
JYHB2400277 | 茚达特罗格隆溴铵吸入粉雾剂 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-06-13 | | | | | view |
JXHS1600048 | 格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs | Import Drug Application | 2016-04-18 | Novartis Europharm Limited | Novartis Europharm Ltd | Certificate Issued | 2018-02-14 | view |
JXHL1300464 | 格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide | Powder for inhalation | Chemical Drugs | Import Drug Application | 2013-12-17 | Novartis Europharm Limited | Novartis Europharm Ltd | Certificate Issued | 2016-02-29 | view |
JXHS1700024 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2017-05-03 | Novartis Europharm Limited | Novartis Europharm Ltd | Certificate Issued | 2018-01-03 | view |
JXHL1400269 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-08-20 | Novartis Europharm Ltd. | Novartis Europharm Ltd | Certificate Issued | 2017-03-07 | view |
JXHL1400166 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-06-06 | Novartis Pharmaceuticals Canada Inc. | Novartis Pharmaceuticals Canada Inc | Certificate Issued | 2016-05-06 | view |
JYHB1901138 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs | Supplementary Application | 2019-09-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-03-01 | view |
JYHB2002066 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-10-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-09-14 | view |
JYHB1900385 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs | Supplementary Application | 2019-03-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2019-04-11 | view |
JYHB1900387 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs | Supplementary Application | 2019-04-01 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-08-07 | view |